Biofrontera Inc (BFRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,478 | -640 | 2,145 | 4,711 | 5,561 |
| Depreciation Amortization | 266 | 1,172 | 394 | 263 | 131 |
| Accounts receivable | -381 | -70 | 2,111 | 1,650 | -1,430 |
| Other Working Capital | 1,356 | 2,788 | 6,952 | 7,541 | 259 |
| Other Operating Activity | 2,548 | -19,449 | -19,530 | -16,152 | -6,633 |
| Operating Cash Flow | $-3,689 | $-16,199 | $-7,928 | $-1,987 | $-2,112 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -5,118 | N/A | N/A | N/A |
| PPE Investments | -14 | -38 | -37 | -36 | -5 |
| Other Investing Activity | 0 | 0 | -3,033 | 0 | 0 |
| Investing Cash Flow | $-14 | $-5,156 | $-3,070 | $-36 | $-5 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 14,021 | 14,021 | 9,391 | N/A |
| Financing Cash Flow | $N/A | $14,021 | $14,021 | $9,391 | $N/A |
| Beginning Cash Position | 17,408 | 24,742 | 24,742 | 24,742 | 24,742 |
| End Cash Position | 13,705 | 17,408 | 27,765 | 32,110 | 22,625 |
| Net Cash Flow | $-3,703 | $-7,334 | $3,023 | $7,368 | $-2,117 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,689 | -16,199 | -7,928 | -1,987 | -2,112 |
| Capital Expenditure | -14 | -38 | -37 | -36 | -5 |
| Free Cash Flow | -3,703 | -16,237 | -7,965 | -2,023 | -2,117 |